• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Correspondence to letter to the editor 1 on "Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study".

作者信息

Jeong Seogsong, Kim Won, Park Sang Min

机构信息

Department of Biomedical Informatics, Korea University College of Medicine, Seoul, Korea.

Biomedical Research Center, Korea University Guro Hospital, Seoul, Korea.

出版信息

Clin Mol Hepatol. 2025 Apr;31(2):e208-e209. doi: 10.3350/cmh.2024.1171. Epub 2025 Jan 6.

DOI:10.3350/cmh.2024.1171
PMID:39761958
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12016588/
Abstract
摘要

相似文献

1
Correspondence to letter to the editor 1 on "Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study".致编辑的信1：关于“代谢功能障碍相关脂肪性肝病的进化变化与肝细胞癌风险：一项全国性队列研究”
Clin Mol Hepatol. 2025 Apr;31(2):e208-e209. doi: 10.3350/cmh.2024.1171. Epub 2025 Jan 6.
2
Correspondence to letter to the editor 2 on "Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study".致编辑的信，回复关于“代谢功能障碍相关脂肪性肝病的进化变化与肝细胞癌风险：一项全国性队列研究”的信2
Clin Mol Hepatol. 2025 Apr;31(2):e210-e211. doi: 10.3350/cmh.2024.1175. Epub 2025 Jan 6.
3
Letter to the editor on "Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study".致编辑的信：关于“代谢功能障碍相关脂肪性肝病的进化变化与肝细胞癌风险：一项全国性队列研究”
Clin Mol Hepatol. 2025 Apr;31(2):e125-e127. doi: 10.3350/cmh.2024.1087. Epub 2024 Dec 17.
4
MAFLD or MASLD: Which better represents the prognosis of the steatotic liver population: Letter to the editor on "Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study".非酒精性脂肪性肝病合并代谢功能障碍或代谢相关脂肪性肝病：哪一个更能代表脂肪性肝病群体的预后：致编辑的信，主题为“代谢功能障碍相关脂肪性肝病的演变及肝细胞癌风险：一项全国性队列研究”
Clin Mol Hepatol. 2025 Apr;31(2):e128-e133. doi: 10.3350/cmh.2024.1008. Epub 2024 Dec 26.
5
Disease Progression for Histologic Diagnosis of Metabolic Dysfunction-Associated Steatotic Liver Disease in the Real-World: A Nationwide US Study.现实世界中代谢功能障碍相关脂肪性肝病组织学诊断的疾病进展：一项美国全国性研究
Dig Dis. 2025;43(1):36-45. doi: 10.1159/000541945. Epub 2024 Oct 14.
6
Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study.代谢相关脂肪性肝病患者发生肝功能障碍的演变及其与肝细胞癌风险的关系：一项全国性队列研究。
Clin Mol Hepatol. 2024 Jul;30(3):487-499. doi: 10.3350/cmh.2024.0145. Epub 2024 May 7.
7
Severity and Remission of Metabolic Dysfunction-Associated Fatty/Steatotic Liver Disease With Chronic Kidney Disease Occurrence.慢性肾脏病发生时代谢功能障碍相关脂肪/脂肪变性肝病的严重程度和缓解情况。
J Am Heart Assoc. 2024 Mar 5;13(5):e032604. doi: 10.1161/JAHA.123.032604. Epub 2024 Feb 23.
8
Pathology and Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatic Tumors.代谢功能障碍相关脂肪性肝病相关肝肿瘤的病理学与发病机制
Biomedicines. 2023 Oct 12;11(10):2761. doi: 10.3390/biomedicines11102761.
9
Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease: Letter to the editor on "Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study".与非酒精性脂肪性肝病和代谢功能障碍相关脂肪性肝病相比，代谢相关脂肪性肝病在预测死亡率方面效果较差：致编辑的信，主题为“经活检确认的代谢功能障碍相关脂肪性肝病的预后：CLIONE研究的亚分析”
Clin Mol Hepatol. 2024 Oct;30(4):974-977. doi: 10.3350/cmh.2024.0417. Epub 2024 Jul 4.
10
Insulin resistance and central obesity determine hepatic steatosis and explain cardiovascular risk in steatotic liver disease.胰岛素抵抗和中心性肥胖决定肝脂肪变性，并解释脂肪性肝病患者的心血管风险。
Front Endocrinol (Lausanne). 2023 Sep 29;14:1244405. doi: 10.3389/fendo.2023.1244405. eCollection 2023.

本文引用的文献

1
Letter to the editor on "Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study".致编辑的信：关于“代谢功能障碍相关脂肪性肝病的进化变化与肝细胞癌风险：一项全国性队列研究”
Clin Mol Hepatol. 2025 Apr;31(2):e125-e127. doi: 10.3350/cmh.2024.1087. Epub 2024 Dec 17.
2
Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease with Increased Alcohol Intake Increase the Risk of Developing Hepatocellular Carcinoma and Incident or Decompensated Cirrhosis: A Korean Nationwide Study.代谢功能障碍相关脂肪性肝病及酒精摄入增加的代谢功能障碍相关脂肪性肝病会增加肝细胞癌和新发或失代偿期肝硬化的发生风险：一项韩国全国性研究
Liver Cancer. 2023 Dec 22;13(4):426-437. doi: 10.1159/000535943. eCollection 2024 Aug.
3
Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in Taiwan.动态变化的代谢相关脂肪性肝病患者的慢性丙型肝炎病毒根除后：一个全国性的登记研究在台湾。
Clin Mol Hepatol. 2024 Oct;30(4):883-894. doi: 10.3350/cmh.2024.0414. Epub 2024 Jul 29.
4
Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study.代谢相关脂肪性肝病患者发生肝功能障碍的演变及其与肝细胞癌风险的关系：一项全国性队列研究。
Clin Mol Hepatol. 2024 Jul;30(3):487-499. doi: 10.3350/cmh.2024.0145. Epub 2024 May 7.
5
Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study.代谢功能障碍相关脂肪性肝病增加心血管疾病发病风险：一项全国性队列研究
EClinicalMedicine. 2023 Oct 28;65:102292. doi: 10.1016/j.eclinm.2023.102292. eCollection 2023 Nov.
6
Reversal of nonalcoholic fatty liver disease reduces the risk of cardiovascular disease among Korean.韩国人的非酒精性脂肪肝疾病逆转降低了心血管疾病的风险。
Medicine (Baltimore). 2023 Nov 3;102(44):e35804. doi: 10.1097/MD.0000000000035804.
7
Association of post-smoking cessation changes in fasting serum glucose with changes in predicted fatty liver score.戒烟后空腹血糖变化与预测性脂肪肝评分变化的关联。
Sci Rep. 2023 Jun 26;13(1):10300. doi: 10.1038/s41598-023-37194-x.
8
The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease.糖尿病和糖尿病前期对非酒精性脂肪性肝病的患病率、并发症和死亡率的影响。
Clin Mol Hepatol. 2022 Jul;28(3):565-574. doi: 10.3350/cmh.2022.0096. Epub 2022 May 19.
9
Association of non-alcoholic fatty liver disease with incident dementia later in life among elder adults.非酒精性脂肪肝疾病与老年人晚年痴呆症发病的相关性。
Clin Mol Hepatol. 2022 Jul;28(3):510-521. doi: 10.3350/cmh.2021.0332. Epub 2022 Mar 17.